CR Bard Revenue and Competitors

New Providence, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CR Bard's estimated annual revenue is currently $803.2M per year.(i)
  • CR Bard's estimated revenue per employee is $251,000

Employee Data

  • CR Bard has 3200 Employees.(i)
  • CR Bard grew their employee count by -5% last year.

CR Bard's People

NameTitleEmail/Phone
1
Staff VP ManufacturingReveal Email/Phone
2
Corp Nat'l Accts VPReveal Email/Phone
3
Regional VPReveal Email/Phone
4
Staff VP ManufacturingReveal Email/Phone
5
Mfg Staff VPReveal Email/Phone
6
Executive Assistant to VP Sales & Global MarketingReveal Email/Phone
7
CEO & PresidentReveal Email/Phone
8
Regional VPReveal Email/Phone
9
Regional VP Corporate AccountsReveal Email/Phone
10
Global VP - Supply ChainReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M3111%N/AN/A
#2
$12.3M49-4%N/AN/A
#3
$15.1M607%N/AN/A
#4
$8.8M35-8%N/AN/A
#5
$3M129%N/AN/A
#6
$300.4M11973%N/AN/A
#7
$311.7M12422%N/AN/A
#8
$0.3M1-96%N/AN/A
#9
$8.3M333%N/AN/A
#10
$13.6M548%N/AN/A
Add Company

What Is CR Bard?

C. R. Bard (www.crbard.com), headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer, and marketer of health care products in the fields of vascular, urology, oncology, and surgical specialty products.

keywords:N/A

N/A

Total Funding

3200

Number of Employees

$803.2M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CR Bard News

2022-04-20 - COVID Illness Delays Bard, AngioDynamics Patent Trial In Del.

Law360 (April 22, 2022, 8:29 PM EDT) -- COVID-19 will delay trial in medical device maker C.R. Bard's patent suit against AngioDynamics after a member of...

2022-04-17 - 2nd Hernia Mesh Bellwether Trial Yields $255k Verdict

Last week, the 2nd bellwether test trial in the C.R. Bard hernia mesh MDL ended in a verdict for the plaintiffs awarding total damages of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22340M233682N/AN/A